3,307 results on '"Diane A"'
Search Results
2. Heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice
3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
4. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
5. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy
6. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
7. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma
8. Granulocyte microvesicles with a high plasmin generation capacity promote clot lysis and improve outcome in septic shock
9. Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
10. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
11. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
12. p53 activation during ribosome biogenesis regulates normal erythroid differentiation
13. PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life
14. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF
15. Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice
16. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
17. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
18. Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
19. A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma
20. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma
21. Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction
22. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
23. Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
24. Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis
25. Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3
26. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
27. MRTF-SRF signaling is required for seeding of HSC/Ps in bone marrow during development
28. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma
29. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia
30. Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy
31. Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
32. A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma
33. Population Pharmacokinetics (PPK) and Exposure-Response to Support Body Surface Area (BSA)-Based Dosing of Brentuximab Vedotin in Pediatric Patients with Advanced-Stage Newly-Diagnosed Hodgkin Lymphoma (HL)
34. Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia
35. Risk Factors Predictive of Cardiac Toxicities from Ibrutinib: A Community-Based Retrospective Cohort Study of Patients with NHL in Northern California
36. CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells
37. Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma
38. Impact of Transfusion Program during Pregnancy on the Obstetrical Outcomes in Sickle Cell Disease Women
39. Higher-order connections between stereotyped subsets
40. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy
41. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study
42. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma
43. A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
44. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
45. Population Pharmacokinetics (PPK) and Exposure-Response to Support Body Surface Area (BSA)-Based Dosing of Brentuximab Vedotin in Pediatric Patients with Advanced-Stage Newly-Diagnosed Hodgkin Lymphoma (HL)
46. Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia
47. CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells
48. Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
49. Impact of Transfusion Program during Pregnancy on the Obstetrical Outcomes in Sickle Cell Disease Women
50. Risk Factors Predictive of Cardiac Toxicities from Ibrutinib: A Community-Based Retrospective Cohort Study of Patients with NHL in Northern California
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.